{"altmetric_id":1872847,"counts":{"readers":{"mendeley":28,"citeulike":0,"connotea":0},"facebook":{"unique_users_count":2,"unique_users":["202969119794991","634052383284995"],"posts_count":2},"total":{"posts_count":17},"twitter":{"unique_users_count":13,"unique_users":["ChasingBoston","Flavio58","thecancergeek","NurseyLulu","breast_C_news","AACR","PenrynPam","SSGMO_KSA","NovelTargets","CancerCureNow","_lung_cancer","Xemadeyaka14","ashp714"],"posts_count":15}},"selected_quotes":["Preclinical activity profile therapeutic efficacy of ganetespib in triple-negative #breastcancer","Work by the EDDC published in May issue of Clinical Cancer Research #Breastcancer #CancerResearch #AACR","Nice new preclinical paper on Hsp90 as a target in TNBC","Manuscript out today re: Hsp90 inhibitors in TN #breastcancer including clinical responses"],"citation":{"abstract":"Treatment options for patients with triple-negative breast cancer (TNBC) are largely limited to systemic chemotherapies, which have shown disappointing efficacy in the metastatic setting. Here, we undertook a comprehensive evaluation of the activity of ganetespib, a potent inhibitor of HSP90, in this malignancy.","abstract_source":"pubmed","altmetric_jid":"4f6fa6113cf058f610006efa","authors":["David A Proia","Chaohua Zhang","Manuel Sequeira","John-Paul Jimenez","Suqin He","Neil L Spector","Geoffrey I. Shapiro","Sara Tolaney","Masazumi Nagai","Jaime Acquaviva","Donald L Smith","Jim Sang","Richard C Bates","Iman El-Hariry","Proia DA","Zhang C","Sequeira M","Jimenez JP","He S","Spector NL","Shapiro GI","Tolaney S","Nagai M","Acquaviva J","Smith DL","Sang J","Bates RC","El-Hariry I","D. A. Proia","C. Zhang","M. Sequeira","J.-P. Jimenez","S. He","N. Spector","G. I. Shapiro","S. Tolaney","M. Nagai","J. Acquaviva","D. L. Smith","J. Sang","R. C. Bates","I. El-Hariry"],"doi":"10.1158\/1078-0432.ccr-13-2166","endpage":"424","first_seen_on":"2013-10-31T13:38:16+00:00","issns":["1557-3265","1078-0432"],"issue":"2","journal":"Clinical Cancer Research","last_mentioned_on":1399477691,"links":["http:\/\/clincancerres.aacrjournals.org\/content\/early\/2013\/10\/30\/1078-0432.CCR-13-2166.abstract?papetoc","http:\/\/clincancerres.aacrjournals.org\/content\/early\/2013\/10\/30\/1078-0432.CCR-13-2166.long","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24173541","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24173541\/","http:\/\/clincancerres.aacrjournals.org\/content\/20\/2\/413.full","http:\/\/clincancerres.aacrjournals.org\/content\/20\/2\/413.short?rss=1","http:\/\/clincancerres.aacrjournals.org\/cgi\/content\/short\/20\/2\/413?rss=1","http:\/\/clincancerres.aacrjournals.org\/content\/early\/2013\/10\/30\/1078-0432.CCR-13-2166.full.pdf+html","http:\/\/www.ncbi.nlm.nih.gov\/m\/pubmed\/24173541\/"],"pdf_url":"http:\/\/clincancerres.aacrjournals.org\/content\/early\/2013\/10\/30\/1078-0432.CCR-13-2166.full.pdf","pmid":"24173541","pubdate":"2013-01-01T00:00:00+00:00","publisher_subjects":[{"name":"Oncology And Carcinogenesis","scheme":"era"}],"scopus_subjects":["Health Sciences","Medicine","Life Sciences","Biochemistry, Genetics and Molecular Biology"],"startpage":"413","title":"Preclinical activity profile and therapeutic efficacy of the Hsp90 inhibitor ganetespib in triple-negative breast cancer.","type":"article","uri":"http:\/\/clincancerres.aacrjournals.org\/cgi\/doi\/10.1158\/1078-0432.CCR-13-2166","volume":"20","mendeley_url":"http:\/\/www.mendeley.com\/research\/preclinical-activity-profile-therapeutic-efficacy-hsp90-inhibitor-ganetespib-triplenegative-breast-c"},"altmetric_score":{"score":7.85,"score_history":{"1y":0,"6m":0,"3m":0,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":7.85},"context_for_score":{"all":{"total_number_of_other_articles":7358329,"mean":6.3926762742804,"rank":925828,"this_scored_higher_than_pct":87,"this_scored_higher_than":6430677,"rank_type":"exact","sample_size":7358329,"percentile":87},"similar_age_3m":{"total_number_of_other_articles":142402,"mean":6.9437432602301,"rank":19147,"this_scored_higher_than_pct":86,"this_scored_higher_than":123216,"rank_type":"exact","sample_size":142402,"percentile":86},"this_journal":{"total_number_of_other_articles":5032,"mean":5.4550065593321,"rank":596,"this_scored_higher_than_pct":88,"this_scored_higher_than":4432,"rank_type":"exact","sample_size":5032,"percentile":88},"similar_age_this_journal_3m":{"total_number_of_other_articles":37,"mean":3.8375555555556,"rank":5,"this_scored_higher_than_pct":86,"this_scored_higher_than":32,"rank_type":"exact","sample_size":37,"percentile":86}}},"demographics":{"poster_types":{"member_of_the_public":10,"researcher":2,"practitioner":1},"users":{"twitter":{"cohorts":{"Members of the public":11,"Practitioners (doctors, other healthcare professionals)":1,"Scientists":1}},"mendeley":{"by_status":{"Student  > Doctoral Student":4,"Researcher":6,"Student  > Ph. D. Student":6,"Student  > Postgraduate":3,"Other":1,"Student  > Master":1,"Student  > Bachelor":5,"Lecturer > Senior Lecturer":1,"Professor":1},"by_discipline":{"Medicine and Dentistry":8,"Chemistry":3,"Agricultural and Biological Sciences":13,"Business, Management and Accounting":2,"Biochemistry, Genetics and Molecular Biology":2}}},"geo":{"twitter":{"US":4,"IT":1,"LA":1},"mendeley":{"CA":1,"US":1,"GB":1}}},"posts":{"twitter":[{"url":"http:\/\/twitter.com\/ChasingBoston\/status\/396257103980933120","license":"public","citation_ids":[1872847],"posted_on":"2013-11-01T12:47:10+00:00","author":{"name":"David Proia, PhD","url":"http:\/\/t.co\/fIv5CCzmpD","image":"http:\/\/pbs.twimg.com\/profile_images\/378800000259774417\/15d177cbd0cc72554e9313dbeed92764_normal.jpeg","description":"Running the 2014 Boston Marathon with the MMRF to raise funds for multiple myeloma while supporting our great city of Boston.","id_on_source":"ChasingBoston","tweeter_id":"1655226745","geo":{"lt":"42.3604823","ln":"-71.0595678","_id":"Boston, MA","country":"US"},"followers":131},"tweet_id":"396257103980933120"},{"url":"http:\/\/twitter.com\/ChasingBoston\/status\/396255952313122816","license":"datasift","citation_ids":[1872847],"posted_on":"2013-11-01T12:42:35+00:00","author":{"name":"David Proia, PhD","url":"http:\/\/t.co\/fIv5CCzmpD","image":"http:\/\/pbs.twimg.com\/profile_images\/378800000259774417\/15d177cbd0cc72554e9313dbeed92764_normal.jpeg","description":"Running the 2014 Boston Marathon with the MMRF to raise funds for multiple myeloma while supporting our great city of Boston.","id_on_source":"ChasingBoston","tweeter_id":"1655226745","geo":{"lt":"42.3604823","ln":"-71.0595678","_id":"Boston, MA","country":"US"},"followers":131},"tweet_id":"396255952313122816"},{"url":"http:\/\/twitter.com\/Flavio58\/status\/429405666210770944","license":"datasift","citation_ids":[1872847],"posted_on":"2014-02-01T00:07:43+00:00","author":{"name":"Flavio Bernardotti","url":"https:\/\/www.facebook.com\/Flavio58","image":"https:\/\/pbs.twimg.com\/profile_images\/812732443987951616\/aYpgetZQ_normal.jpg","description":"On  the networks since 1985. Computer security, hacking, cracking, computer vision, AI, military spy systems (tempest), electronic. Lunatic insane.","id_on_source":"Flavio58","tweeter_id":"17228282","geo":{"lt":45,"ln":8,"country":"IT"},"followers":2000},"tweet_id":"429405666210770944"},{"url":"http:\/\/twitter.com\/thecancergeek\/status\/397777308741672960","license":"public","citation_ids":[1872847],"posted_on":"2013-11-05T17:27:55+00:00","author":{"name":"Angela Alexander","url":"http:\/\/thecancergeek.wordpress.com\/","image":"https:\/\/pbs.twimg.com\/profile_images\/430641398031740928\/Edjlb7tB_normal.jpeg","description":"#InflammatoryBreastCancer #clinicaltrials geek @ MD Anderson. #TNBC & #sarcoma interest. Patient advocacy, cancer edu volunteer. Tweets=my views only. \uf8ff fan.","id_on_source":"thecancergeek","tweeter_id":"14155350","geo":{"lt":29.76328,"ln":-95.36327,"country":"US"},"followers":2955},"tweet_id":"397777308741672960"},{"url":"https:\/\/twitter.com\/NurseyLulu\/status\/404134605923827712","license":"public","citation_ids":[1872847],"posted_on":"2013-11-23T06:29:33+00:00","author":{"name":"Lulubelle","url":"http:\/\/t.co\/gOA1lVCs6g","image":"http:\/\/pbs.twimg.com\/profile_images\/388586346\/209_normal.jpg","description":"Mother, Daughter, Sister, Friend, Nurse, http:\/\/t.co\/u6NEUdx2UT webmaster, 4 time Breast Cancer patient, BRCA 2 carrier and all round BC bore :","id_on_source":"NurseyLulu","tweeter_id":"69988556","geo":{"lt":"18.9261759","ln":"102.4483016","country":"LA"},"followers":119},"tweet_id":"404134605923827712"},{"url":"http:\/\/twitter.com\/breast_C_news\/status\/405624353116520448","license":"public","citation_ids":[1872847],"posted_on":"2013-11-27T09:09:16+00:00","author":{"name":"breast_C_news","image":"http:\/\/pbs.twimg.com\/profile_images\/431249932268236800\/cMe6i6tv_normal.png","description":"Breast Cancer Scientific News","id_on_source":"breast_C_news","tweeter_id":"2210905584","followers":5},"tweet_id":"405624353116520448"},{"url":"http:\/\/twitter.com\/AACR\/status\/424262510888615936","license":"public","citation_ids":[1872847],"posted_on":"2014-01-17T19:30:39+00:00","author":{"name":"AACR","url":"http:\/\/www.aacr.org","image":"https:\/\/pbs.twimg.com\/profile_images\/483648447971463168\/J-CUuLt4_normal.jpeg","description":"The mission of the American Association for Cancer Research is to prevent and cure cancer through research, education, communication, and collaboration.","id_on_source":"AACR","tweeter_id":"14617444","geo":{"lt":39.95234,"ln":-75.16379,"country":"US"},"followers":51491},"tweet_id":"424262510888615936"},{"url":"http:\/\/twitter.com\/PenrynPam\/status\/424266410790232064","license":"public","rt":["AACR"],"citation_ids":[1872847],"posted_on":"2014-01-17T19:46:09+00:00","author":{"name":"Penryn Pam","url":"http:\/\/www.winahomeforlife.co.uk","image":"http:\/\/pbs.twimg.com\/profile_images\/378800000059758588\/318006b9c592aa8c55f6880a711ce896_normal.jpeg","description":"Supporting #BreastCancer - Women need to feel they have a voice when going through Breast Cancer - Page not monitored daily - Enquiries @WinAHome4Life","id_on_source":"PenrynPam","tweeter_id":"1553822702","geo":{"_id":"pam@winnit.co.uk"},"followers":1110},"tweet_id":"424266410790232064"},{"url":"http:\/\/twitter.com\/SSGMO_KSA\/status\/427815538178666496","license":"public","rt":["AACR"],"citation_ids":[1872847],"posted_on":"2014-01-27T14:49:07+00:00","author":{"name":"SSGMO","url":"http:\/\/www.ssgmo.org","image":"https:\/\/pbs.twimg.com\/profile_images\/559811289346613248\/hmhAvdCa_normal.png","description":"Saudi Society for Genomics and Molecular Oncology strives to eradicate cancer through innovative research","id_on_source":"SSGMO_KSA","tweeter_id":"1069362740","followers":1063},"tweet_id":"427815538178666496"},{"url":"http:\/\/twitter.com\/NovelTargets\/status\/464069191155200000","license":"datasift","citation_ids":[1872847],"posted_on":"2014-05-07T15:48:11+00:00","author":{"name":"Novel Targets","url":"http:\/\/www.jimmyfundwalk.org\/2014\/noveltargets#sthash.reGDxjx5.dpuf","image":"https:\/\/pbs.twimg.com\/profile_images\/495252260616560640\/uWi9GpvM_normal.jpeg","description":"Official Twitter page of the Early Drug Development Center at Dana-Farber Cancer Institute. The EDDC seeks to find novel treatments for solid tumors.","id_on_source":"NovelTargets","tweeter_id":"2457144714","geo":{"lt":42.35843,"ln":-71.05977,"country":"US"},"followers":15},"tweet_id":"464069191155200000"},{"url":"http:\/\/twitter.com\/CancerCureNow\/status\/395906483243606016","license":"public","citation_ids":[1872847],"posted_on":"2013-10-31T13:33:55+00:00","author":{"name":"Cure Cancer Now","url":"http:\/\/cancercure-d.blogspot.com\/","image":"https:\/\/pbs.twimg.com\/profile_images\/1128872809\/Hep_G2_Lab_test_normal.jpg","description":"Pure science is what it is taking to defeat cancer. Follow us to be a part of history in the making. Receive only the best information here.","id_on_source":"CancerCureNow","tweeter_id":"193691326","geo":{"lt":null,"ln":null},"followers":8383},"tweet_id":"395906483243606016"},{"url":"http:\/\/twitter.com\/_lung_cancer\/status\/410179167250952192","license":"public","citation_ids":[1872847],"posted_on":"2013-12-09T22:48:28+00:00","author":{"name":"Lung Cancer News","image":"http:\/\/pbs.twimg.com\/profile_images\/431464299505016832\/iQP17KUP_normal.jpeg","description":"Lung Cancer News","id_on_source":"_lung_cancer","tweeter_id":"2161616756","followers":7},"tweet_id":"410179167250952192"},{"url":"http:\/\/twitter.com\/ChasingBoston\/status\/425935027042811904","license":"public","rt":["AACR"],"citation_ids":[1872847],"posted_on":"2014-01-22T10:16:38+00:00","author":{"name":"David Proia, PhD","url":"http:\/\/t.co\/fIv5CCzmpD","image":"http:\/\/pbs.twimg.com\/profile_images\/378800000259774417\/15d177cbd0cc72554e9313dbeed92764_normal.jpeg","description":"Running the 2014 Boston Marathon with the MMRF to raise funds for multiple myeloma while supporting our great city of Boston.","id_on_source":"ChasingBoston","tweeter_id":"1655226745","geo":{"lt":"42.3604823","ln":"-71.0595678","_id":"Boston, MA","country":"US"},"followers":131},"tweet_id":"425935027042811904"},{"url":"http:\/\/twitter.com\/Xemadeyaka14\/status\/424469102380732416","license":"public","rt":["AACR"],"citation_ids":[1872847],"posted_on":"2014-01-18T09:11:34+00:00","author":{"name":"Xema P\u00e9rez","image":"https:\/\/pbs.twimg.com\/profile_images\/378800000756361229\/739d351e4f914138a6380d0c66e2f909_normal.jpeg","id_on_source":"Xemadeyaka14","tweeter_id":"2184430467","geo":{"lt":null,"ln":null},"followers":374},"tweet_id":"424469102380732416"},{"url":"http:\/\/twitter.com\/ashp714\/status\/424263264177233920","license":"public","rt":["AACR"],"citation_ids":[1872847],"posted_on":"2014-01-17T19:33:39+00:00","author":{"name":"Ashley Phillips","image":"https:\/\/pbs.twimg.com\/profile_images\/378800000470779929\/15a43d3cc2eab7672a96489f2860805e_normal.jpeg","description":"Proud mother of 4. Married 15 years. Fighting cancer for my husband and kids. #BreastCancer Reasearch Advocate","id_on_source":"ashp714","tweeter_id":"1876966056","geo":{"lt":null,"ln":null},"followers":484},"tweet_id":"424263264177233920"}],"facebook":[{"title":"Preclinical Activity Profile and Therapeutic Efficacy of the HSP90 Inhibitor Ganetespib in Triple-Ne","url":"https:\/\/www.facebook.com\/202969119794991\/posts\/512188125565822","license":"public","citation_ids":[1872847],"posted_on":"2014-02-01T00:07:42+00:00","summary":"Purpose: Treatment options for patients with triple-negative breast cancer (TNBC) are largely limited to systemic chemotherapies, which have shown disappointing efficacy in the metastatic setting. Here, we undertook a comprehensive evaluation of the \u2026","author":{"name":"News su HIV, Cancro e Salute.","url":"https:\/\/www.facebook.com\/202969119794991","facebook_wall_name":"News su HIV, Cancro e Salute.","image":"https:\/\/graph.facebook.com\/202969119794991\/picture","id_on_source":"202969119794991"}},{"title":"Preclinical activity profile and therapeutic... [Clin Cancer Res. 2013] - PubMed - NCBI","url":"https:\/\/www.facebook.com\/permalink.php?story_fbid=664577156899184&id=634052383284995","license":"public","citation_ids":[1872847],"posted_on":"2013-11-24T14:17:08+00:00","summary":"http:\/\/www.ncbi.nlm.nih.gov\/m\/pubmed\/24173541\/","author":{"name":"Metaplastic Breast Cancer Stage 4","url":"https:\/\/www.facebook.com\/634052383284995","facebook_wall_name":"Metaplastic Breast Cancer Stage 4","image":"https:\/\/graph.facebook.com\/634052383284995\/picture","id_on_source":"634052383284995"}}]}}